Recherche - Stabilis 4.0

Dernière mise à jour :
17/12/2025

Rechercher

Cyclophosphamide		Cyclophosphamide (Grande Bretagne, Etats Unis d’Amérique, Arabie Saoudite, Nouvelle Zélande) ATC : L01AA01
Cyclophosphamide		ATC : L01AA01
Cyclophosphamide		ATC : L01AA01
40	Pharm Sci Communications	Stability and compatibility studies of four cytostatic agents (fluorouracil, dacarbazine, cyclophosphamide and ifosfamide) with PVC infusion bags.
50	Am J Health-Syst Pharm	Stability of ondansetron hydrochloride and cyclophosphamide in injectable solutions.
170	Am J Hosp Pharm	Effect of briefly heating cyclophosphamide solutions.
172	J Parenter Sci Technol	Chemical stability of two sterile, parenteral formulations of cyclophosphamide (Endoxan) after reconstitution and dilution in commonly used infusion fluids.
1728	Pharmazie	Stability of cyclophosphamide containing infusions.
1833	Ann Pharmacotherapy	Stability of cyclophosphamide and mesna admixtures in polyethylene infusion bags.
2000	J Pharm Biomed Anal	Quality control and stability study using HPTLC: applications to cyclophosphamide in various pharmaceutical products.
2016	Am J Health-Syst Pharm	Compatibility of palonosetron with cyclophosphamide and with ifosfamide during Y-site administration.
3096	Ann Pharmacotherapy	Stability of Cyclophosphamide in Extemporaneous Oral Suspensions.
4865	Dr REDDY laboratoire	Cyclophosphamide REDDY PHARMA 2000 mg/4 ML, solution à diluer pour solution injectable/perfusion. - Résumé des caractéristiques du produit.
4989	Dr REDDY	Extended dilution stability study report of cyclophosphamide concentrate for solution for infusion at room temperature and refrigerated condition ( 2-8°C) - Personal communication - July 2025

Mentions Légales